Clinical Trials Directory

Trials / Completed

CompletedNCT02577952

Lipodystrophy Connect Patient Registry

Status
Completed
Phase
Study type
Observational
Enrollment
257 (actual)
Sponsor
PatientCrossroads · Industry
Sex
All
Age
Healthy volunteers
Accepted

Summary

Lipodystrophy Connect is an online survey tool designed to collect demographic data and health information from individuals with Lipodystrophy.

Detailed description

Lipodystrophy is a heterogeneous group of rare and inherited syndromes characterized by the complete or partial loss or absence of subcutaneous adipose tissue. People living with lipodystrophy lack the fat tissue required for normal metabolic function. To enhance knowledge of the underlying biology of these conditions and to institute effective clinical treatments, the Lipodystrophy community has developed a mechanism for individuals with any of the Lipodystrophy conditions to enroll in a Lipodystrophy registry called Lipodystrophy Connect. The objective of such a registry is to create a platform that connects all of the Lipodystrophy community, including persons with Lipodystrophy, family members, healthcare providers, researchers, drug companies, advocacy groups, federal research organizations, and regulators. A patient registry will provide the foundation for a resource to meet the current and future needs of the Lipodystrophy community as well as accelerate the rate of research and development of therapies that improve the quality of life of those with Lipodystrophy. Lipodystrophy Connect is an online survey tool that collects basic demographic information and health information from people with any rare form of Lipodystrophy.

Conditions

Timeline

Start date
2014-01-01
Primary completion
2018-11-08
Completion
2018-11-08
First posted
2015-10-16
Last updated
2019-04-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02577952. Inclusion in this directory is not an endorsement.